{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:17:54Z","timestamp":1762507074213},"reference-count":27,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.5144\/0256-4947.2015.468","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T10:42:35Z","timestamp":1490438555000},"page":"468-471","source":"Crossref","is-referenced-by-count":9,"title":["Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports"],"prefix":"10.5144","volume":"35","author":[{"given":"Hussain","family":"Alizadeh","sequence":"first","affiliation":[{"name":"Kaposi M\u00f3r Teaching Hospital, Kaposv\u00e1r, Hungary"},{"name":"Tawam Hospital, AlAin-United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Jaafar","sequence":"additional","affiliation":[{"name":"Tawam Hospital, AlAin-United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Kajt\u00e1r","sequence":"additional","affiliation":[{"name":"P\u00e9cs University, Faculty of General Medicine, Department of Pathology, P\u00e9cs-Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"key":"e_1_3_3_2_2","first-page":"413","article-title":"Case of hypertrophy of the spleen and liver in which death took place from suppuration of the blood","volume":"64","author":"Bennett J","year":"1845","journal-title":"Edinb Med Surg J"},{"key":"e_1_3_3_3_2","first-page":"1497","article-title":"A minute chromosome in human chronic granulocytic leukemia","volume":"132","author":"Noowell PC","year":"1960","journal-title":"Science"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley JD","year":"1973","journal-title":"Nature"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myeloid leukemia in mice by the p210 bcr-abl gene of the Philadelphia chromosome","volume":"247","author":"Daley GQ","year":"1990","journal-title":"Science"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/306239a0","article-title":"Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia","volume":"306","author":"Heisterkamp N","year":"1983","journal-title":"Nature"},{"issue":"17","key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers CL","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl S","year":"1999","journal-title":"N Engl J Med"},{"key":"e_1_3_3_9_2","first-page":"368a","article-title":"Clinical efficacy and safety of an Abl specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia","volume":"94","author":"Druker BJ","year":"1999","journal-title":"Blood"},{"issue":"1","key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI9083","article-title":"Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia","volume":"105","author":"Druker Brian J","year":"2000","journal-title":"J Clin Invest"},{"issue":"19","key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood-2010-03-273979","article-title":"Long-term prognostic significance of early molecular response to Imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)","volume":"116","author":"Hughes TP","year":"2010","journal-title":"Blood"},{"issue":"4","key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2605.2007.00755.x","article-title":"Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat","volume":"30","author":"Nurmio M","year":"2007","journal-title":"Int J Androl"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.jp.7211665","article-title":"Imatinib mesylate and metabolite concentration in maternal blood, umbilical cord blood, placenta and breast milk","volume":"27","author":"Russel MA","year":"2007","journal-title":"J Perinatol"},{"issue":"12","key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1124\/dmd.108.022764","article-title":"Lacteal secretion, fetal and maternal tissue distribution of dasatinib in rats","volume":"26","author":"He K","year":"2008","journal-title":"Drug Metabol Disp"},{"issue":"2","key":"e_1_3_3_15_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/shem.2003.50038","article-title":"Imatinib treatment: specific issues related to safety, fertility, and pregnancy","volume":"40","author":"Hensley ML","year":"2003","journal-title":"Semin Hematol"},{"issue":"1","key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"e2014028","DOI":"10.4084\/mjhid.2014.028","article-title":"Tyrosine Kinase Inhibitors and Pregnancy","volume":"6","author":"Elisabetta A","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0609.2005.00420.x","article-title":"Imatinib in pregnancy","volume":"74","author":"Alkindi S","year":"2005","journal-title":"Eur J Haematol"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1200\/JCO.2005.04.6557","article-title":"Pregnancy among patients with chronic myeloid leukemia treated with imatinib","volume":"24","author":"Ault P","year":"2006","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1182\/blood-2007-10-114900","article-title":"The effects of Imatinib on pregnancy outcome","volume":"111","author":"Pye SM","year":"2008","journal-title":"Blood"},{"issue":"4","key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3816\/CLM.2009.n.064","article-title":"Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature","volume":"9","author":"Cole S","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"Abstract 3230: Poster presented at: the 50th American Society of Hematology (ASH) Annual Meeting San Francisco USA December 6\u20139 2008 Blood 112 J Cortes S O\u2019Brien P Ault G Borthakur E Jabbour B Bradley-Garelik Pregnancy outcomes among patients with chronic myeloid leukemia treated with dasatinib 2008","DOI":"10.1182\/blood.V112.11.3230.3230"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-8722-2-42","article-title":"Two successful pregnancies in a women with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study","volume":"2","author":"Conchon M","year":"2009","journal-title":"J Hematol Oncol"},{"issue":"10","key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.leukres.2013.07.020","article-title":"Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor","volume":"37","author":"Zhou L","year":"2013","journal-title":"Leuk Res"},{"issue":"1","key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1098-1101(1999)14:1<42::AID-JCA8>3.0.CO;2-2","article-title":"Management of chronic myeloid leukemia during pregnancy with leukapheresis","volume":"14","author":"Strobl FJ","year":"1999","journal-title":"J Clin Apheresis"},{"issue":"1","key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<101::AID-AJH23>3.0.CO;2-D","article-title":"Interferon-alpha therapy for chronicmyelogenous leukemia during pregnancy","volume":"59","author":"Kuroiwa M","year":"1998","journal-title":"Am J Hematol"},{"issue":"9","key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2000.079009803.x","article-title":"Hydroxyurea treatment for chronic myeloid leukemia during pregnancy","volume":"79","author":"Celiloglu M","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2013-08-283580","article-title":"How I treat leukemia during pregnancy","volume":"123","author":"Milojkovic Dragana","year":"2014","journal-title":"Blood"},{"key":"e_1_3_3_28_2","first-page":"184","article-title":"Discontinuation of tyrosine kinase inhibitors in CML: when is this a safe option to consider?","author":"Sweet Kendra","year":"2013","journal-title":"Americal Society of Hematology Educational Book, ASH"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol35\/vol35iss6\/838.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T07:04:40Z","timestamp":1719126280000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2015.468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.5144\/0256-4947.2015.468"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2015.468","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}